Nabla, a leading AI assistant provider in clinical care, has raised $70 million in Series C funding led by HV Capital, with Highland Europe joining as a key investor alongside DST Global and existing investors Cathay Innovation and Tony Fadell's Build Collective. This latest round brings the company's total funding to $120 million.
The funding arrives as Nabla experiences significant market traction, with its AI assistant now deployed across more than 130 healthcare organizations, including major academic medical centers, safety-net hospitals, and physician groups. The platform currently supports over 85,000 clinicians and 20 million annual encounters, with revenue multiplying by five over the past six months.
Nabla plans to use the capital to transform its offering from ambient documentation into what it calls an "agentic model" of clinical AI. This evolution will enhance clinical documentation integrity, initiate electronic health record actions, and adapt across various care settings to support diverse clinical roles. The company aims to unify ambient listening, dictation, coding, and command capabilities into a single extensible platform.
The investment will accelerate development of Nabla's Adaptive Agentic Platform, which includes several key components. The Proactive Coding Agent will improve real-time support for ICD-10, HCC, and MCC coding, with upcoming features to guide E/M coding and surface compliance nudges. The Context-Aware Agent will expand use of historical data to introduce smarter documentation, initiate orders, and direct EHR commands through an intuitive interface. Additionally, the Custom Care Setting Agent will deploy new capabilities tailored for nurses and other frontline roles, with early expansion into inpatient environments.
"We're going even deeper into clinical workflows while continuing to offer a highly customizable assistant that works across specialties," said Alex Lebrun, co-founder and CEO of Nabla. "Clinicians already trust our accuracy and speed, and this funding allows us to expand that impact by embedding intelligent support directly into care delivery."
The platform has demonstrated measurable impact across its user base. Leading health systems including CVS Health, Children's Hospital Los Angeles, and the University of Iowa Health Care have implemented Nabla's solution. The technology helps clinicians reduce documentation time by more than half, according to the company. Peer-reviewed studies from the University of Iowa Health Care and real-world data from Denver Health have confirmed significant reductions in clinician burnout and a 15-point increase in patient satisfaction.
The new funding will support product development, fuel growth across Nabla's technical and go-to-market teams, and enable strategic partnerships to expand the AI assistant into new care settings. The company's long-term vision focuses on building a proactive assistant that intuitively streamlines clinical workflows while delivering impact at a national scale.
Click here for the original news story.